Document is current
Any future updates will be listed below
-
Authors
Lanzani, Guglielmo https://orcid.org/0000-0002-2442-4495
Chiaravalli, Greta https://orcid.org/0000-0003-4979-3446
Colombo, Elisabetta https://orcid.org/0000-0002-7998-9397
Manfredi, Giovanni https://orcid.org/0000-0003-0682-0731
Di Marco, Stefano https://orcid.org/0000-0003-4847-6270
Vurro, Vito https://orcid.org/0000-0001-8519-1990
Benfenati, Fabio https://orcid.org/0000-0002-0653-8368
- License Information
-
More Information
Article History
Accepted: 10 June 2024
First Online: 18 July 2024
Competing interests
: G.L. and F.B. are consultants of Novavido S.r.l., a company that develops organic retinal prostheses. Poly(3-hexylthiophene) nanoparticle technology is the subject of US patent application US 16/005,248 “<i>Eye-injectable polymeric nanoparticles and method of use therefor</i>” by Istituto Italiano di Tecnologia and Ospedale Sacrocuore Don Calabria that is licensed to Novavido S.r.l.
